Grimes & Company Inc. Has $1.03 Million Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Grimes & Company Inc. significantly reduced its stake in UnitedHealth Group by 85.7%, now holding 3,285 shares valued at approximately $1.03 million.
• UnitedHealth Group reported earnings per share of $4.08 for the last quarter, missing estimates, with revenues of $111.62 billion compared to a forecast of $111.75 billion.
• The company has a dividend yield of 2.5% after announcing a quarterly dividend of $2.21 per share, with a payout ratio of 38.30%.

Grimes & Company Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 85.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,285 shares of the healthcare conglomerate's stock after selling 19,720 shares during the period. Grimes & Company Inc.'s holdings in UnitedHealth Group were worth $1,025,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the first quarter valued at about $42,000. Kentucky Trust Co increased its stake in shares of UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock worth $45,000 after purchasing an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC boosted its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.3%

UNH opened at $358.95 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market cap of $325.09 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.34 and a beta of 0.47. The firm's 50-day simple moving average is $309.38 and its 200-day simple moving average is $352.34. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research report on Friday, September 12th. KeyCorp cut their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research report on Friday, September 5th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Hold" and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.